Arch Therapeutics, Inc. Annual Return On Equity in % from 2013 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Arch Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2013 to 2023.
  • Arch Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 121 %, a 15.5% increase year-over-year.
  • Arch Therapeutics, Inc. annual Return On Equity for 2023 was 100 %, a 34.8% decline from 2022.
  • Arch Therapeutics, Inc. annual Return On Equity for 2022 was 154 %, a 94.3% decline from 2021.
  • Arch Therapeutics, Inc. annual Return On Equity for 2021 was 2.69K %, a 253% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 100 -53.7 -34.8% Oct 1, 2022 Sep 30, 2023
2022 154 -2.54K -94.3% Oct 1, 2021 Sep 30, 2022
2021 2.69K +1.93K +253% Oct 1, 2020 Sep 30, 2021
2020 763 -224 -22.7% Oct 1, 2019 Sep 30, 2020
2019 987 +1.21K Oct 1, 2018 Sep 30, 2019
2018 -219 +26.8 +10.9% Oct 1, 2017 Sep 30, 2018
2017 -246 +49.1 +16.7% Oct 1, 2016 Sep 30, 2017
2016 -295 -418 -338% Oct 1, 2015 Sep 30, 2016
2015 124 -13.4 -9.78% Oct 1, 2014 Sep 30, 2015
2014 137 +3.29K Oct 1, 2013 Sep 30, 2014
2013 -3.15K Oct 1, 2012 Sep 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.